Economic Value of Adjunctive Brivaracetam Treatment Strategy for Focal Onset Seizures in Finland.

These simulated comparisons demonstrated that brivaracetam was more effective and potentially also more affordable than perampanel. Thus, brivaracetam is likely a cost-effective and net beneficial alternative to perampanel for treatment of focal onset seizures. Plain language summary available for this article.